Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.478 | Gaps in Awareness of Cardiovascular Diseases: A Cross Sectional Study | Professor Yan Ping Yen Bryan |
| 2024.481 | SA-BioPercept study: A survey study on biologics initiation from the perspective of moderate-tosevere asthma patients | Prof. HUI David Shu Cheong |
| 2024.484 | A qualitative evaluation of the perceptions of nursing staff to patient safety culture after the implementation of structured “Hand-in-hand nurse round and digital rounding report” (“手牽手護理監察計劃及日常電子監察報告”) program in Hong Kong | Ward Manager Lau Suet Ying Frances |
| 2024.488 | Elucidation of a novel pathogenic fungus Rhizopus arrhizus in promoting steatotic liver disease-related liver cancer | Prof. ZHANG Xiang |
| 2024.492 | A proactive approach to prevent non-communicable diseases through screening and educating emergency department attendees to adopt healthy lifestyles: A randomised clinical trial | Professor Li Ho Cheung William |
| 2024.512 | A randomized controlled trial evaluating a Chatbot-delivered theory-based online intervention in increasing seasonal influenza vaccination uptake among children aged 3-6 years | Dr. WANG Zixin |
| 2024.519 | The clinical characteristics and genetics of thyroid hormone resistance syndrome β in public hospitals of Hong Kong: A retrospective study | Dr Chow Edith Wing Kar |
| 2024.522 | A retrospective multi-centre cohort study on patients with Pneumocystis jirovecii pneumonia requiring intensive care in Hong Kong | Dr. CHAN Ka Lee |
| 2024.523 | A retrospective multi-centre cohort study on patients with Pneumocystis jirovecii pneumonia requiring intensive care in Hong Kong | Dr. LAM Ka Hing |
| 2024.524 | A retrospective multi-centre cohort study on patients with Pneumocystis jirovecii pneumonia requiring intensive care in Hong Kong | Dr. HO Lap Tin |
| 9406(S) | A Prospective Randomized Phase III Study Comparing the Combination of Cisplatin, Doxorubicin, Interferon-Alpha-2B and 5-Fluorouracil to Doxorubicin Alone in the Treatment of Inoperable Hepatocellular Carcinoma | Prof. YEO Winnie |
Page 254 of 254.